Work

Alternating Oxaliplatin and Irinotecan Chemotherapy Combined With Capecitabine and Bevacizumab for Microsatellite-stable Stage IV Metastatic Colon Cancer With a BRAF V600E Mutation: Two Case Reports Indicating Survival Improvement over Standard Therapy

Year: 2024

Type: article

Study design: Case Report

Source: Anticancer Research

DOI: 10.21873/anticanres.17428

Authors: YAOYI ZHANG, XIAOHUI LI, SHENG LI, ZHIJIAN YANG, ROBERT M. HOFFMAN, CHEN YU

Institutions: Jiangsu Cancer Hospital, Nanjing Medical University, AntiCancer (United States), University of California San Diego

Language: English

Topic: Colorectal Cancer Treatments and Studies

Subfield: Oncology

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: closed

OpenAlex ID: W4405948993

FWCI:

Cites:

Cited by:

Related to: 10